Total n (%) | Crohn disease n (%) | Ulcerative colitis n (%) | |
Total | 1009 | 728 | 281 |
Any extraintestinal manifestation* | 285 (28.2) | 218 (29.9) | 67 (23.8) |
Arthralgia | 166 (16.5) | 124 (17) | 42 (14.9) |
Aphthous stomatitis | 81 (8) | 72 (9.9)¶ | 9 (3.2)¶ |
Arthritis | 37 (3.7) | 32 (4.4) | 5 (1.8) |
Erythema nodosum | 28 (2.8) | 26 (3.6)Δ | 2 (0.71)Δ |
Primary sclerosing cholangitis | 15 (1.5) | 7 (1)◊ | 8 (2.8)◊§ |
Pancreatitis | 9 (0.9) | 5 (0.7) | 4 (1.4) |
Chronic active hepatitis | 6 (0.6) | 2 (0.3) | 4 (1.4) |
Iritis or uveitis | 7 (0.7) | 6 (0.8) | 1 (0.4) |
Ankylosing spondylitis | 4 (0.4) | 4 (0.5) | 0 |
Pyoderma gangrenosum | 3 (0.3) | 3 (0.4) | 0 |
* Number of individual subjects with one or more extraintestinal manifestations.
¶ p<0.001 for Crohn disease versus ulcerative colitis.
Δ p<0.01 for Crohn disease versus ulcerative colitis.
◊ p = 0.039 for Crohn disease versus ulcerative colitis.
§ The prevalence of primary sclerosing cholangitis may be as high as 10% among pediatric patients with ulcerative colitis, according to a study using rigorous case-finding methods[1].Reproduced with permission from: Dotson JL, Hyams JS, Markowitz J, et al. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr 2010; 51:140. DOI: 10.1097/MPG.0b013e3181ca4db4. Copyright © 2010 ESPGHAN and NASPGHAN. Unauthorized reproduction of this material is prohibited.